In light of these beneficial effects, it remains to be investigated whether AHDS patients receiving a high dose of TRIAC as early as possibly after birth respond to the TRIAC treatment in a similarly positive manner as Mct8/Oatp1c1 DKO mice. Here, SLC16A2 is linked to Allan-Herndon-Dudley syndrome.